MAPT and Alzheimer disease: To date, although there are several diagnostic methods for dementia, such as clinical approaches, neuroimaging techniques, measurement of CSF levels of Aβ and tau (for AD), and digital biomarkers, both the sensitivity and specificity of diagnosis remains insufficient.